Cyclosporin a as an Add-On Therapy to a High Dose Corticosteroid-Based Background Treatment in Patients With COVID-19: A Multicenter Randomized Clinical Trial
How to cite: Llanos Jiménez, L.; Alvarez-Alvarez, B.; Fonseca Aizpuru, E.; Peces-Barba, G.; Pindao Quesada, G.; Rodriguez Nieto, M. J.; Ruíz-Hornillos, F. J.; Seijo Maceiras, L.; Robles Barrena, I.; Mena-de-Cea, Á.; Meijide-Míguez, H.; Sánchez-Pernaute, O. Cyclosporin a as an Add-On Therapy to a High Dose Corticosteroid-Based Background Treatment in Patients With COVID-19: A Multicenter Randomized Clinical Trial. Preprints 2024, 2024072075. https://doi.org/10.20944/preprints202407.2075.v1 Llanos Jiménez, L.; Alvarez-Alvarez, B.; Fonseca Aizpuru, E.; Peces-Barba, G.; Pindao Quesada, G.; Rodriguez Nieto, M. J.; Ruíz-Hornillos, F. J.; Seijo Maceiras, L.; Robles Barrena, I.; Mena-de-Cea, Á.; Meijide-Míguez, H.; Sánchez-Pernaute, O. Cyclosporin a as an Add-On Therapy to a High Dose Corticosteroid-Based Background Treatment in Patients With COVID-19: A Multicenter Randomized Clinical Trial. Preprints 2024, 2024072075. https://doi.org/10.20944/preprints202407.2075.v1
Abstract
Keywords
Subject
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)